Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein-DNA complex organization	TDRD5 KDM3A BPTF KMT2C TLK1 EP400 CENPE MTHFR ATF7IP BRD4 CENPI POGZ SUZ12 BCL7A KMT2E MYBL1	6.86e-07	999	77	16	GO:0071824
GeneOntologyBiologicalProcess	chromatin organization	TDRD5 KDM3A BPTF KMT2C TLK1 EP400 MTHFR ATF7IP BRD4 CENPI SUZ12 BCL7A KMT2E MYBL1	5.05e-06	896	77	14	GO:0006325
GeneOntologyBiologicalProcess	chromatin remodeling	TDRD5 KDM3A BPTF KMT2C EP400 ATF7IP BRD4 CENPI SUZ12 BCL7A KMT2E MYBL1	1.82e-05	741	77	12	GO:0006338
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	BCL9L KDM3A BPTF KMT2C ZEB1 MRTFB HIVEP2 NFATC2 BCLAF1 ASXL3 BRD4 APBB2 POU2F2 POGZ MYBL1 ZNF292	4.50e-05	1390	77	16	GO:0045944
GeneOntologyCellularComponent	nuclear protein-containing complex	BCL9L KDM3A BPTF KMT2C WDR5B INTS12 AFF2 EP400 NFATC2 UBAP2L BCLAF1 ASXL3 BRD4 NABP2 SUZ12 NUP42 BCL7A KMT2E	7.18e-06	1377	84	18	GO:0140513
GeneOntologyCellularComponent	postsynaptic density	CELSR3 GPR158 DTNB CAMK2G GRIA3 EEF2K GRIN2B ATP2B2 PDLIM5 ABHD17C	1.31e-05	451	84	10	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	CELSR3 GPR158 DTNB CAMK2G GRIA3 EEF2K GRIN2B ATP2B2 PDLIM5 ABHD17C	2.13e-05	477	84	10	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	CELSR3 GPR158 DTNB CAMK2G GRIA3 EEF2K GRIN2B ATP2B2 PDLIM5 ABHD17C	3.34e-05	503	84	10	GO:0099572
GeneOntologyCellularComponent	postsynaptic density membrane	CELSR3 GPR158 GRIA3 GRIN2B ATP2B2 ABHD17C	4.09e-05	157	84	6	GO:0098839
GeneOntologyCellularComponent	neuron to neuron synapse	CELSR3 GPR158 DTNB CAMK2G GRIA3 EEF2K GRIN2B ATP2B2 PDLIM5 ABHD17C	4.63e-05	523	84	10	GO:0098984
GeneOntologyCellularComponent	postsynaptic specialization membrane	CELSR3 GPR158 GRIA3 GRIN2B ATP2B2 ABHD17C	1.60e-04	201	84	6	GO:0099634
GeneOntologyCellularComponent	presynaptic active zone membrane	CELSR3 GRIA3 GRIN2B ATP2B2	2.76e-04	78	84	4	GO:0048787
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	BPTF EP400 SUZ12 BCL7A	6.08e-04	96	84	4	GO:0070603
GeneOntologyCellularComponent	parallel fiber to Purkinje cell synapse	GRIA3 GRIN2B ATP2B2	6.88e-04	43	84	3	GO:0098688
GeneOntologyCellularComponent	myofibril	AKAP4 MYOT PDE4DIP GRIN2B PDLIM5 MYBPC1	8.14e-04	273	84	6	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	AKAP4 MYOT PDE4DIP GRIN2B PDLIM5 MYBPC1	1.11e-03	290	84	6	GO:0043292
GeneOntologyCellularComponent	PcG protein complex	UBAP2L ASXL3 SUZ12	1.20e-03	52	84	3	GO:0031519
GeneOntologyCellularComponent	ATPase complex	BPTF EP400 SUZ12 BCL7A	1.82e-03	129	84	4	GO:1904949
GeneOntologyCellularComponent	postsynapse	CELSR3 GPR158 DTNB CAMK2G TNK2 GRIA3 EEF2K GRIN2B ATP2B2 PDLIM5 ABHD17C	2.48e-03	1018	84	11	GO:0098794
GeneOntologyCellularComponent	presynaptic active zone	CELSR3 GRIA3 GRIN2B ATP2B2	2.52e-03	141	84	4	GO:0048786
GeneOntologyCellularComponent	dendritic spine	GRIA3 EEF2K GRIN2B ATP2B2 ABHD17C	2.93e-03	242	84	5	GO:0043197
GeneOntologyCellularComponent	neuron spine	GRIA3 EEF2K GRIN2B ATP2B2 ABHD17C	3.20e-03	247	84	5	GO:0044309
GeneOntologyCellularComponent	Z disc	AKAP4 MYOT GRIN2B PDLIM5	3.23e-03	151	84	4	GO:0030018
GeneOntologyCellularComponent	nuclear body	ILRUN AFF2 SBF1 EP400 BMP2K BCLAF1 ATF7IP CENPI SUZ12 KMT2E	3.29e-03	903	84	10	GO:0016604
GeneOntologyCellularComponent	sarcomere	AKAP4 MYOT GRIN2B PDLIM5 MYBPC1	3.31e-03	249	84	5	GO:0030017
GeneOntologyCellularComponent	histone methyltransferase complex	KMT2C WDR5B SUZ12	3.43e-03	75	84	3	GO:0035097
HumanPheno	Self-injurious behavior	KMT2C UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ KMT2E	4.31e-06	210	25	8	HP:0100716
HumanPheno	Aggressive behavior	BPTF KMT2C HIVEP2 AFF2 UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ KMT2E	1.23e-05	516	25	11	HP:0000718
HumanPheno	Abnormal aggressive, impulsive or violent behavior	BPTF KMT2C HIVEP2 AFF2 UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ KMT2E	1.23e-05	516	25	11	HP:0006919
HumanPheno	Severe expressive language delay	KMT2C GRIA3 POGZ	2.23e-05	12	25	3	HP:0006863
HumanPheno	Facial hypotonia	MYOT CAMK2G GRIA3 POGZ	7.59e-05	48	25	4	HP:0000297
HumanPheno	Abnormal social development	BPTF KMT2C HIVEP2 AFF2 UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ GRIN2B KMT2E ZNF292	1.05e-04	908	25	13	HP:0025732
HumanPheno	Abnormal response to social norms	BPTF KMT2C HIVEP2 AFF2 UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ KMT2E ZNF292	1.62e-04	807	25	12	HP:5200123
HumanPheno	Social disinhibition	BPTF KMT2C HIVEP2 AFF2 UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ KMT2E ZNF292	1.62e-04	807	25	12	HP:5200029
HumanPheno	Disinhibition	BPTF KMT2C HIVEP2 AFF2 UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ KMT2E ZNF292	1.62e-04	807	25	12	HP:0000734
HumanPheno	Inappropriate behavior	BPTF KMT2C HIVEP2 AFF2 UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ KMT2E ZNF292	1.62e-04	807	25	12	HP:0000719
HumanPheno	Synophrys	BPTF HIVEP2 UBAP2L ASXL3 BRD4 ZNF292	2.81e-04	195	25	6	HP:0000664
HumanPheno	Abnormally increased volition	BPTF KMT2C HIVEP2 AFF2 UBAP2L ASXL3 CAMK2G BRD4 GRIA3 POGZ KMT2E ZNF292	3.34e-04	869	25	12	HP:5200263
HumanPheno	Abnormality of the palpebral fissures	BPTF KMT2C HIVEP2 CENPE UBAP2L ASXL3 CAMK2G BRD4 POGZ SUZ12 KMT2E ZNF292	3.77e-04	880	25	12	HP:0008050
HumanPheno	Facial hypertrichosis	BPTF HIVEP2 UBAP2L ASXL3 BRD4 ZNF292	3.78e-04	206	25	6	HP:0002219
HumanPheno	Diagnostic behavioral phenotype	KMT2C HIVEP2 AFF2 UBAP2L MTHFR ASXL3 BRD4 GRIA3 POGZ GRIN2B ZNF292	3.90e-04	747	25	11	HP:0025783
MousePheno	increased dendritic spine density	GPR158 POGZ GRIN2B	9.89e-06	9	70	3	MP:0020507
Domain	LRRC37AB_C	LRRC37A LRRC37A3 LRRC37A2	3.25e-07	4	82	3	PF14914
Domain	LRRC37_N	LRRC37A LRRC37A3 LRRC37A2	3.25e-07	4	82	3	IPR032754
Domain	LRRC37AB_C	LRRC37A LRRC37A3 LRRC37A2	3.25e-07	4	82	3	IPR029423
Domain	LRRC37	LRRC37A LRRC37A3 LRRC37A2	3.25e-07	4	82	3	PF15779
Domain	LRRC37A/B-like	LRRC37A LRRC37A3 LRRC37A2	3.25e-07	4	82	3	IPR015753
Domain	ZF_PHD_2	BPTF KMT2C INTS12 ASXL3 KMT2E	6.13e-05	95	82	5	PS50016
Domain	ZF_PHD_1	BPTF KMT2C INTS12 ASXL3 KMT2E	6.45e-05	96	82	5	PS01359
Domain	PHD	BPTF KMT2C INTS12 KMT2E	3.31e-04	75	82	4	PF00628
Domain	Znf_PHD-finger	BPTF KMT2C INTS12 KMT2E	4.04e-04	79	82	4	IPR019787
Domain	Znf_FYVE_PHD	KDM3A BPTF KMT2C INTS12 KMT2E	4.73e-04	147	82	5	IPR011011
Domain	PHD	BPTF KMT2C INTS12 KMT2E	6.35e-04	89	82	4	SM00249
Domain	Znf_PHD	BPTF KMT2C INTS12 KMT2E	6.90e-04	91	82	4	IPR001965
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KDM3A BPTF KMT2C MRTFB EP400 UBAP2L BCLAF1 BRD4 ATG2B SEC16A POGZ ANKHD1 PDLIM5	9.99e-10	549	86	13	38280479
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9L BPTF KMT2C FOXP4 ZEB1 HIVEP2 EP400 ASXL3 SEC16A POGZ BCL7A	1.18e-09	351	86	11	38297188
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	KMT2C FOXP4 ZEB1 EP400 BAIAP2L1 ATF7IP BRD4 SEC16A POGZ SUZ12 ZNF292	4.36e-09	398	86	11	35016035
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PRUNE2 KMT2C TLK1 MRTFB GPR158 SEC16A TRIOBP TLN2 TNRC6C	5.05e-09	225	86	9	12168954
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KDM3A BPTF TLK1 ZEB1 EP400 UBAP2L BCLAF1 BRD4 SEC16A HELZ TLN2 YBX3 POGZ SUZ12	6.72e-09	774	86	14	15302935
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZEB1 MRTFB ZNF532 ATF7IP CAMK2G BRD4 ATG2B SEC16A POGZ ANKHD1 ZMYM5	7.23e-09	418	86	11	34709266
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A LRRC37A3 LRRC37A2	5.83e-08	4	86	3	22419166
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KDM3A KMT2C MAST4 CELSR3 SBF1 EP400 ZNF532 BCLAF1 TRIOBP POGZ ANKHD1	7.95e-08	529	86	11	14621295
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ZEB1 SBF1 CENPE GPR158 UBAP2L BCLAF1 ATF7IP CAMK2G PDE4DIP SEC16A TRIOBP GRIA3 TLN2 GRIN2B	1.01e-07	963	86	14	28671696
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	KMT2C FOXP4 HIVEP2 NFATC2 ZNF532 BRD4 ZNF185 POU2F2 POGZ RNF139 PDLIM5 ZNF292	1.81e-07	709	86	12	22988430
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	SBF1 BMP2K UBAP2L BCLAF1 CAMK2G TRIOBP HELZ YBX3 POGZ ANKHD1 PDLIM5 ZNF292	2.27e-07	724	86	12	36232890
Pubmed	Human transcription factor protein interaction networks.	BCL9L BPTF KMT2C FOXP4 ZEB1 INTS12 EP400 UBAP2L ATF7IP SEC16A HELZ YBX3 POGZ TNRC6C BCL7A ANKHD1	3.88e-07	1429	86	16	35140242
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KMT2C TLK1 HIVEP2 CELSR3 SBF1 EP400 MTHFR BRD4 SEC16A TNK2 TLN2 TNRC6C BCL7A ANKHD1	5.31e-07	1105	86	14	35748872
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A HIVEP2 CELSR3 ZNF532 NABP2 PDE4DIP APBB2 TRIOBP TLN2 POGZ GRIN2B NUP42 PDLIM5 ZMYM5 ZNF292	5.60e-07	1285	86	15	35914814
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	BPTF ZEB1 INTS12 BRD4 ZNF347 POU2F2 POGZ NUP42 PDLIM5 ZMYM5 MYBL1 ZNF292	7.23e-07	808	86	12	20412781
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PRUNE2 MRTFB AFF2 EP400 BAIAP2L1 ZNF532 TNK2 KMT2E ZMYM5	1.23e-06	430	86	9	35044719
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A LRRC37A3 LRRC37A2	1.73e-06	10	86	3	23064749
Pubmed	Expression QTL and regulatory network analysis of microtubule-associated protein tau gene.	BPTF APBB2 EEF2K	2.37e-06	11	86	3	19233709
Pubmed	A human MAP kinase interactome.	KMT2C TLK1 HIVEP2 ATF7IP HELZ TNK2 EVPL POGZ NUP42	3.35e-06	486	86	9	20936779
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRUNE2 BPTF KMT2C FOXP4 TLK1 MRTFB HIVEP2 ZNF532 GPR158 UBAP2L DTNB APBB2 TRIOBP TNK2 TNRC6C	3.46e-06	1489	86	15	28611215
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	BPTF FOXP4 NFATC2 BCLAF1 HELZ ISG20L2 SUZ12 BCL7A	3.92e-06	370	86	8	22922362
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	BCL9L GPR158 UBAP2L BCLAF1 CAMK2G U2SURP PDE4DIP ATG2B TRIOBP HELZ GRIA3 TLN2 GRIN2B	4.42e-06	1139	86	13	36417873
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	KDM3A TLK1 MRTFB EP400 BAIAP2L1 BCLAF1 BRD4 U2SURP YBX3	4.64e-06	506	86	9	30890647
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9L FOXP4 INTS12 EP400 BRD4 U2SURP BCL7A	4.77e-06	268	86	7	33640491
Pubmed	Hematopoietic stem cell transplantation without irradiation.	BCLAF1 KMT2E	6.04e-06	2	86	2	19270698
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PRUNE2 MAST4 U2SURP SEC16A TLN2	6.23e-06	104	86	5	9205841
Pubmed	Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+.	CAMK2G GRIA3 GRIN2B	6.50e-06	15	86	3	9481670
Pubmed	Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.	KDM3A BPTF CENPE BCLAF1 YBX3	1.06e-05	116	86	5	21282530
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	BPTF TLK1 INTS12 DTNB BCLAF1 CAMK2G U2SURP GRIA3 ISG20L2 YBX3 MINDY2 ATP2B2 MYBPC1 ZNF292	1.16e-05	1442	86	14	35575683
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MRTFB INTS12 EP400 BAIAP2L1 CENPE ATF7IP SEC16A HELZ NUP42	1.54e-05	588	86	9	38580884
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	BMP2K UBAP2L SEC16A HELZ TNRC6C ANKHD1 PDLIM5	1.57e-05	322	86	7	39098523
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	KDM3A BPTF KMT2C TLK1 INTS12 EP400 BCLAF1 CAMK2G BRD4 U2SURP POGZ ZNF292	1.72e-05	1103	86	12	34189442
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	BCL9L KMT2C MRTFB INTS12 SBF1 EP400 NFATC2 BMP2K TRIOBP HELZ ISG20L2 SUZ12 BCL7A ANKHD1	1.75e-05	1497	86	14	31527615
Pubmed	ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.	KDM3A TNK2	1.81e-05	3	86	2	25148682
Pubmed	mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression.	ATF7IP SUZ12	1.81e-05	3	86	2	14536086
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MRTFB EP400 UBAP2L BCLAF1 ATF7IP U2SURP ATG2B SEC16A HELZ ANKHD1 PDLIM5	1.93e-05	934	86	11	33916271
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KMT2C UBAP2L PDE4DIP KMT2E ANKHD1 ZNF292	2.55e-05	233	86	6	37704626
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	BPTF BCLAF1 SEC16A TRIOBP EVPL ANKHD1 PDLIM5	3.20e-05	360	86	7	33111431
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	BPTF KMT2C EP400 SEC16A POGZ	3.22e-05	146	86	5	23892456
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	BCL9L CELSR3 CENPE BCLAF1 ASXL3 TLN2 YBX3	3.26e-05	361	86	7	26167880
Pubmed	The histone demethylase, Jmjd1a, interacts with the myocardin factors to regulate SMC differentiation marker gene expression.	KDM3A MRTFB	3.61e-05	4	86	2	17991879
Pubmed	Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding.	ASXL3 BRD4	3.61e-05	4	86	2	34536441
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SECISBP2L ILRUN MRTFB BMP2K UBAP2L BCLAF1 SEC16A EEF2K POGZ TNRC6C PDLIM5	5.03e-05	1038	86	11	26673895
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	BPTF EP400 POGZ ZNF292	5.52e-05	83	86	4	28794006
Pubmed	PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning.	CAMK2G GRIN2B	6.01e-05	5	86	2	28636948
Pubmed	NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.	BPTF BRD4	6.01e-05	5	86	2	26626481
Pubmed	Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B.	CAMK2G GRIN2B	6.01e-05	5	86	2	16436603
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	BPTF KMT2C FOXP4 EP400 POGZ	6.12e-05	167	86	5	20362541
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EP400 UBAP2L PDE4DIP SEC16A POGZ SUZ12 TNRC6C	6.93e-05	407	86	7	12693553
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	BPTF SBF1 EP400 ZNF532 BCLAF1 BRD4 U2SURP TRIOBP POGZ BCL7A ZNF292	7.30e-05	1082	86	11	38697112
Pubmed	The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor.	BMP2K BRD4 GRIN2B	7.55e-05	33	86	3	19336002
Pubmed	Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2.	CAMK2G GRIN2B	9.01e-05	6	86	2	16120608
Pubmed	Bromodomain Protein BRD4 Is Essential for Hair Cell Function and Survival.	BRD4 GRIA3	9.01e-05	6	86	2	33015071
Pubmed	Habituation in prepulse inhibition is affected by a polymorphism on the NMDA receptor 2B subunit gene (GRIN2B).	MTHFR GRIN2B	9.01e-05	6	86	2	20421849
Pubmed	Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.	TLN2 GRIN2B	9.01e-05	6	86	2	20197096
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	BPTF FOXP4 EP400 MTHFR BRD4 SEC16A HELZ POGZ SUZ12 BCL7A ANKHD1	9.59e-05	1116	86	11	31753913
Pubmed	HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders.	CAMK2G GRIA3 GRIN2B	1.16e-04	38	86	3	25613138
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	KDM3A TLK1 EP400 UBAP2L ZNF185 SEC16A ZMYM5	1.19e-04	444	86	7	34795231
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	BPTF EP400 UBAP2L BCLAF1 ATF7IP BRD4 U2SURP SEC16A YBX3 POGZ	1.24e-04	954	86	10	36373674
Pubmed	CKAMP44: a brain-specific protein attenuating short-term synaptic plasticity in the dentate gyrus.	GRIA3 GRIN2B	1.26e-04	7	86	2	20185686
Pubmed	Brain spectrin binding to the NMDA receptor is regulated by phosphorylation, calcium and calmodulin.	CAMK2G GRIN2B	1.26e-04	7	86	2	9670010
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	AFF2 EP400 BAIAP2L1 BMP2K BCLAF1 ATF7IP SEC16A APBB2 EEF2K	1.31e-04	777	86	9	35844135
Pubmed	Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1.	TLK1 UBAP2L SUZ12	1.45e-04	41	86	3	8590280
Pubmed	Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.	UBAP2L HELZ ANKHD1 PDLIM5	1.48e-04	107	86	4	30995489
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BCL9L BPTF KMT2C EP400 UBAP2L BRD4 SUZ12	1.67e-04	469	86	7	27634302
Pubmed	Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation.	BPTF KMT2C	1.68e-04	8	86	2	21447625
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	KMT2C KMT2E	1.68e-04	8	86	2	23130995
Pubmed	Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes.	AKAP4 PDE4DIP	1.68e-04	8	86	2	17923693
Pubmed	Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo.	KDM3A KMT2C SUZ12	1.80e-04	44	86	3	24183668
Pubmed	Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression.	BPTF ZNF292	2.15e-04	9	86	2	28319097
Pubmed	TBR1 regulates autism risk genes in the developing neocortex.	POGZ GRIN2B	2.15e-04	9	86	2	27325115
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	BPTF SBF1 UBAP2L U2SURP SEC16A HELZ POGZ ANKHD1	2.17e-04	653	86	8	22586326
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	FOXP4 UBAP2L BCLAF1 U2SURP SEC16A HELZ YBX3 ANKHD1	2.21e-04	655	86	8	35819319
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	SBF1 MTHFR PDE4DIP EEF2K ZNF292	2.37e-04	223	86	5	33187986
Pubmed	Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.	KDM3A KMT2C KMT2E	2.48e-04	49	86	3	34368113
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	HIVEP2 UBAP2L TRIOBP EEF2K PDLIM5	2.52e-04	226	86	5	25900982
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	MRTFB BCLAF1 NUP42 ZNF292	2.53e-04	123	86	4	26912792
Pubmed	The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.	INTS12 ATF7IP ZMYM5	2.63e-04	50	86	3	26275350
Pubmed	ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.	ASXL3 BRD4	2.68e-04	10	86	2	32669118
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	BPTF FOXP4 INTS12 EP400 NFATC2 POU2F2 POGZ ANKHD1 ANKRD26P1	2.72e-04	857	86	9	25609649
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	SBF1 SEC16A APBB2 PLEKHA1 ANKHD1	2.73e-04	230	86	5	35449600
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP2 MAST4 INTS12 SBF1 BAIAP2L1 BRD4 SEC16A PLEKHA1 HELZ	2.81e-04	861	86	9	36931259
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	HIVEP2 SBF1 HELZ EEF2K SUZ12	2.84e-04	232	86	5	25515538
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	CELSR3 BCLAF1 ASXL3 U2SURP ATG2B YBX3 MINDY2	2.87e-04	513	86	7	25798074
Pubmed	Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population.	MTHFR GRIN2B PDLIM5	2.96e-04	52	86	3	19328558
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	CELSR3 EP400 UBAP2L U2SURP	3.12e-04	130	86	4	12421765
Pubmed	Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).	TLK1 BCLAF1 SUZ12	3.49e-04	55	86	3	27114453
Pubmed	Identification of proteins associated with ligand-activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS.	EP400 UBAP2L BCLAF1 U2SURP YBX3	3.65e-04	245	86	5	21182205
Pubmed	The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.	BAIAP2L1 BRD4 BCL7A	3.88e-04	57	86	3	21555454
Pubmed	New nomenclature for chromatin-modifying enzymes.	KDM3A KMT2C KMT2E	3.88e-04	57	86	3	18022353
Pubmed	Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.	CAMK2G GRIN2B	3.93e-04	12	86	2	8615909
Pubmed	Developmental rearrangements of cortical glutamate-NMDA receptor binding sites in late human gestation.	CAMK2G GRIN2B	3.93e-04	12	86	2	8665664
Pubmed	Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle.	CAMK2G GRIN2B	3.93e-04	12	86	2	12815021
Pubmed	RBPMS is an RNA-binding protein that mediates cardiomyocyte binucleation and cardiovascular development.	CAMK2G PDLIM5	3.93e-04	12	86	2	35472321
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	BPTF CENPI HELZ EEF2K NUP42	4.00e-04	250	86	5	33536335
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	KMT2C TLK1 CAMK2G BRD4 CENPI SEC16A HELZ SUZ12 RNF139 ABHD17C ZNF292	4.26e-04	1327	86	11	32694731
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	EP400 BRD4 U2SURP POGZ SUZ12 BCL7A	4.46e-04	394	86	6	27248496
Pubmed	Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol.	GRIA3 GRIN2B	4.63e-04	13	86	2	20859245
Pubmed	A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve.	ASXL3 BCL7A	4.63e-04	13	86	2	36325906
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	BAIAP2L1 UBAP2L BCLAF1 BRD4 SEC16A PDLIM5	4.77e-04	399	86	6	35987950
Interaction	EGR2 interactions	BCL9L KMT2C FOXP4 HIVEP2 EP400 PDE4DIP SEC16A POGZ BCL7A	3.54e-08	171	83	9	int:EGR2
Interaction	HNF1B interactions	BPTF KMT2C ZEB1 EP400 BCLAF1 ATF7IP POGZ BCL7A	1.16e-06	190	83	8	int:HNF1B
Interaction	LHX2 interactions	BCL9L KMT2C FOXP4 TLK1 EP400 POGZ BCL7A	1.05e-05	183	83	7	int:LHX2
Interaction	SRF interactions	BPTF FOXP4 ZEB1 MRTFB POGZ ZNF292	2.36e-05	139	83	6	int:SRF
Interaction	ACTC1 interactions	KDM3A TLK1 MRTFB EP400 BAIAP2L1 BCLAF1 BRD4 U2SURP YBX3 GRIN2B SUZ12 BCL7A	2.61e-05	694	83	12	int:ACTC1
Interaction	MEX3B interactions	UBAP2L SEC16A HELZ YBX3 SUZ12 TNRC6C ANKHD1	3.66e-05	222	83	7	int:MEX3B
Interaction	AR interactions	BCL9L KDM3A KMT2C FOXP4 INTS12 EP400 UBAP2L BRD4 U2SURP SEC16A TNK2 POU2F2 SUZ12 BCL7A	4.95e-05	992	83	14	int:AR
Interaction	NUP43 interactions	BCL9L KDM3A BPTF MRTFB EP400 ZNF532 BCLAF1 ATF7IP POGZ NUP42 ZNF292	4.98e-05	625	83	11	int:NUP43
Interaction	WWTR1 interactions	BPTF ZEB1 EP400 BRD4 ATG2B SEC16A POGZ ANKHD1 PDLIM5	5.94e-05	422	83	9	int:WWTR1
Interaction	TERF2IP interactions	KDM3A BPTF ZEB1 EP400 ATF7IP BRD4 U2SURP POGZ SUZ12 ZNF292	8.86e-05	552	83	10	int:TERF2IP
Interaction	FBXO42 interactions	MRTFB INTS12 EP400 CENPE SEC16A HELZ NUP42	9.65e-05	259	83	7	int:FBXO42
Interaction	YY1 interactions	BPTF FOXP4 INTS12 EP400 ATF7IP BRD4 POGZ SUZ12 KMT2E	1.04e-04	454	83	9	int:YY1
Interaction	TBR1 interactions	BCL9L KMT2C FOXP4 BRD4 BCL7A	1.04e-04	113	83	5	int:TBR1
Interaction	ELF4 interactions	BPTF EP400 ATF7IP POGZ BCL7A	1.13e-04	115	83	5	int:ELF4
Interaction	KDM1A interactions	ZEB1 MRTFB EP400 NFATC2 ZNF532 ATF7IP CAMK2G BRD4 PDE4DIP ATG2B SEC16A POGZ ANKHD1	1.17e-04	941	83	13	int:KDM1A
Interaction	RBBP4 interactions	BPTF ZEB1 NFATC2 ZNF532 ASXL3 BRD4 YBX3 SUZ12 KMT2E MYBL1	1.20e-04	573	83	10	int:RBBP4
Interaction	B4GALT2 interactions	SBF1 EP400 CAMK2G HELZ ANKHD1	1.33e-04	119	83	5	int:B4GALT2
Interaction	HNF4A interactions	BPTF KMT2C EP400 ATF7IP POGZ SUZ12 BCL7A	1.40e-04	275	83	7	int:HNF4A
Interaction	KLF5 interactions	KMT2C FOXP4 EP400 BRD4 SEC16A BCL7A	1.55e-04	195	83	6	int:KLF5
Interaction	KDM3A interactions	KDM3A MRTFB BRD4 TNK2	1.68e-04	67	83	4	int:KDM3A
Interaction	UHRF2 interactions	BPTF TLK1 INTS12 BCLAF1 BRD4 SUZ12	1.77e-04	200	83	6	int:UHRF2
Interaction	CELF1 interactions	UBAP2L BRD4 HELZ YBX3 NUP42 TNRC6C ANKHD1	1.86e-04	288	83	7	int:CELF1
Interaction	FEV interactions	KMT2C FOXP4 ZEB1 EP400 POGZ BCL7A	1.92e-04	203	83	6	int:FEV
Interaction	R3HDM2 interactions	SECISBP2L UBAP2L SEC16A HELZ TNRC6C	1.94e-04	129	83	5	int:R3HDM2
Interaction	SOX2 interactions	BCL9L BPTF KMT2C FOXP4 ZEB1 EP400 BCLAF1 ZNF185 SEC16A TRIOBP HELZ EVPL POGZ BCL7A ANKHD1 ZNF292	1.97e-04	1422	83	16	int:SOX2
Interaction	HCFC1 interactions	KMT2C EP400 UBAP2L ASXL3 BRD4 SUZ12 KMT2E	2.07e-04	293	83	7	int:HCFC1
Interaction	FUBP3 interactions	UBAP2L BRD4 SEC16A HELZ SUZ12 NUP42 TNRC6C	2.24e-04	297	83	7	int:FUBP3
Interaction	TBC1D4 interactions	EP400 CAMK2G U2SURP NABP2 APBB2	2.39e-04	135	83	5	int:TBC1D4
Interaction	BNIP5 interactions	MTHFR ANKHD1 PDLIM5	2.52e-04	30	83	3	int:BNIP5
Interaction	SP7 interactions	BCL9L KMT2C FOXP4 INTS12 EP400 POGZ BCL7A	2.59e-04	304	83	7	int:SP7
Interaction	CDKN2AIPNL interactions	BCLAF1 BRD4 SEC16A	2.79e-04	31	83	3	int:CDKN2AIPNL
Interaction	TOP3B interactions	KMT2C TLK1 HIVEP2 CELSR3 SBF1 EP400 UBAP2L MTHFR BRD4 SEC16A HELZ TNK2 TLN2 TNRC6C BCL7A ANKHD1	2.87e-04	1470	83	16	int:TOP3B
GeneFamily	PHD finger proteins	BPTF KMT2C INTS12 KMT2E	1.61e-04	90	55	4	88
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BPTF KMT2C TLK1 ZEB1 HIVEP2 EP400 NFATC2 BCLAF1 ATF7IP U2SURP PDE4DIP HELZ TNK2 POU2F2 SUZ12 TNRC6C KMT2E RNF139 ZMYM5 MYBL1 ZNF292	1.03e-08	1492	86	21	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SECISBP2L KDM3A BPTF TLK1 ZEB1 HIVEP2 BMP2K CENPE U2SURP APBB2 HELZ SUZ12 PDLIM5 MYBL1 ZNF292	1.14e-07	856	86	15	M4500
Coexpression	GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN	SECISBP2L KMT2C GPR158 DTNB SEC16A EEF2K TNRC6C	2.18e-06	180	86	7	M8906
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	SECISBP2L MAST4 AFF2 CELSR3 GPR158 ASXL3 PDE4DIP PLEKHA1 TNK2 POU2F2 TLN2 TNRC6C KMT2E ATP2B2	1.39e-05	1106	86	14	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	BPTF TLK1 HIVEP2 CENPE U2SURP HELZ SUZ12 MYBL1 ZNF292	2.25e-05	466	86	9	M13522
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	KMT2C TLK1 UBAP2L BCLAF1 BRD4 TRIOBP BCL7A ANKHD1 ABHD17C	2.29e-05	467	86	9	M1347
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN	KDM3A BPTF ZEB1 MRTFB HIVEP2 NFATC2 PDE4DIP PLEKHA1 TNRC6C ANKRD36C BCL7A MYBL1 ZNF292	2.50e-05	1012	86	13	M40864
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	KMT2C TLK1 UBAP2L BCLAF1 BRD4 TRIOBP BCL7A ANKHD1 ABHD17C	3.03e-05	484	86	9	MM999
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	BPTF NFATC2 BCLAF1 ATF7IP HELZ TNK2 POU2F2 TNRC6C KMT2E RNF139 MYBL1 ZNF292	4.16e-05	911	86	12	M40038
Coexpression	GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP	TLK1 MRTFB COQ9 NABP2 LRRC37A2 MYBL1	4.38e-05	194	86	6	M6103
Coexpression	BASAKI_YBX1_TARGETS_DN	SECISBP2L PRUNE2 BPTF MAST4 PLEKHA1 HELZ EEF2K MINDY2	4.98e-05	398	86	8	M14877
Coexpression	GSE31082_DN_VS_DP_THYMOCYTE_DN	SECISBP2L TRIOBP TNRC6C KMT2E MINDY2 ZMYM5	5.18e-05	200	86	6	M5055
Coexpression	GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP	KDM3A HIVEP2 TRIOBP BCL7A RNF139 MINDY2	5.18e-05	200	86	6	M7841
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	BPTF TLK1 HIVEP2 MAST4 HELZ POGZ BCL7A	5.95e-05	300	86	7	M8702
Coexpression	CHANDRAN_METASTASIS_UP	BPTF KMT2C EP400 GPR158 KMT2E PDLIM5	6.62e-05	209	86	6	M16036
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2B	AFF2 NFATC2 CENPE LRRC37A3 TNK2 YBX3 ATP2B2 PDLIM5	9.85e-05	439	86	8	M39054
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	NFATC2 ASXL3 PDE4DIP PLEKHA1 TNK2 POU2F2 TLN2 TNRC6C ATP2B2 ZNF292	1.02e-04	703	86	10	M39070
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP	TLK1 MRTFB HIVEP2 MYOT BCLAF1 GRIA3 ANKRD36C BCL7A ZXDA	1.32e-04	587	86	9	M40869
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BPTF KMT2C BCLAF1 ATF7IP HELZ KMT2E ZNF292	1.23e-07	200	86	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	ST6GALNAC1 BAIAP2L1 GRIA3 ANKRD36C ABHD17C MYBPC1	1.55e-06	184	86	6	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L ZEB1 ATF7IP APBB2 YBX3 BCL7A	1.81e-06	189	86	6	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ZEB1 HIVEP2 MAST4 TNRC6C ANKRD36C KMT2E	2.16e-06	195	86	6	4bdedd924564a260841a9153604026b57487c83d
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	BPTF TLK1 BCLAF1 BRD4 SEC16A SUZ12	2.36e-06	198	86	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	BPTF BCLAF1 PDE4DIP ANKRD36C KMT2E ZNF292	2.36e-06	198	86	6	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	BPTF BCLAF1 BRD4 PLEKHA1 YBX3 KMT2E	2.43e-06	199	86	6	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	BPTF BCLAF1 BRD4 U2SURP SUZ12 ZNF292	2.43e-06	199	86	6	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	BPTF BCLAF1 BRD4 U2SURP KMT2E ZNF292	2.43e-06	199	86	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BPTF KMT2C ZEB1 MRTFB MAST4 TNK2	2.50e-06	200	86	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Mild/Remission-B_naive-4\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SECISBP2L ATF7IP PLEKHA1 YBX3 BCL7A	1.01e-05	148	86	5	dd5e1bc02824e743e1c030a303e32f27a359a8ca
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF2 ZNF185 POU2F2 BCL7A MYBL1	1.30e-05	156	86	5	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	COVID-CD4-CD4_Treg\|COVID / Condition, Cell_class and T cell subcluster	ZEB1 MAST4 BAIAP2L1 BCL7A ZMYM5	1.43e-05	159	86	5	037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	POGZ GRIN2B KMT2E ZXDA ZNF292	1.81e-05	167	86	5	3b717d33aaf1ef0869cc4bca8432ba8008875cc5
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SECISBP2L ATF7IP PLEKHA1 YBX3 BCL7A	1.92e-05	169	86	5	c3a6179a64589a370108fea809b157839347759c
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF2 CENPE POU2F2 BCL7A MYBL1	2.15e-05	173	86	5	b7e0193fd4983cb38d1bee441f608f73ee8743b9
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	BAIAP2L1 GRIA3 ANKRD36C ABHD17C MYBPC1	2.81e-05	183	86	5	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	(4)_B_cells-(4)_B_mantle\|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ATF7IP APBB2 PLEKHA1 YBX3 BCL7A	2.81e-05	183	86	5	21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	AFF2 CENPE CENPI BCL7A MYBL1	2.96e-05	185	86	5	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NFATC2 CENPE SIGLEC9 CENPI POU2F2	3.12e-05	187	86	5	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L ZEB1 ATF7IP YBX3 BCL7A	3.20e-05	188	86	5	d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ATF7IP APBB2 POU2F2 YBX3 BCL7A	3.28e-05	189	86	5	e2bb5900d210386b7b74938e7a3636d0c7ba1bcf
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L ZEB1 ATF7IP POU2F2 BCL7A	3.54e-05	192	86	5	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	BPTF CENPE BRD4 ANKRD36C ZNF292	3.54e-05	192	86	5	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SECISBP2L PDE4DIP APBB2 BCL7A KMT2E	3.81e-05	195	86	5	ecaaa3d071e763c40d05d088fbf9e8ca06f78f47
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ST6GALNAC1 HIVEP2 MAST4 PDE4DIP ANKRD36C	3.81e-05	195	86	5	22191d361af136942508f1553ff41a626ed982ad
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZEB1 ATF7IP PLEKHA1 ANKRD36C ZNF292	3.81e-05	195	86	5	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MRTFB GPR158 GRIA3 GRIN2B ATP2B2	3.90e-05	196	86	5	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	BPTF KMT2C NFATC2 MYBL1 ZNF292	3.90e-05	196	86	5	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCL9L NFATC2 TNRC6C ANKRD36C MYBL1	4.00e-05	197	86	5	59b1fb93a39dcf8c994d2b7dc2906dae74c57527
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MRTFB GPR158 GRIA3 GRIN2B ATP2B2	4.09e-05	198	86	5	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MRTFB GPR158 GRIA3 GRIN2B ATP2B2	4.09e-05	198	86	5	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BPTF ATF7IP ANKRD36C MYBL1 ZNF292	4.19e-05	199	86	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	BPTF BCLAF1 BRD4 KMT2E ZNF292	4.19e-05	199	86	5	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	Transverse-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	WDR5B AFF2 TLN2 BCL7A MYBL1	4.19e-05	199	86	5	170ae68963d31f3b821b6f0e8f0c039bea0bc981
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB1 HIVEP2 MAST4 YBX3 PDLIM5	4.29e-05	200	86	5	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 GPR158 TNK2 GRIA3 GRIN2B	4.29e-05	200	86	5	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 GPR158 TNK2 GRIA3 GRIN2B	4.29e-05	200	86	5	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 GPR158 TNK2 GRIA3 GRIN2B	4.29e-05	200	86	5	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	BPTF ZEB1 MRTFB MAST4 TNK2	4.29e-05	200	86	5	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 GPR158 TNK2 GRIA3 GRIN2B	4.29e-05	200	86	5	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	severe-B_naive\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ATF7IP APBB2 POU2F2 YBX3 BCL7A	4.29e-05	200	86	5	306df1f498ac2188eaf9f2a8d002bb73bdb9642d
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 GPR158 TNK2 GRIA3 GRIN2B	4.29e-05	200	86	5	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 GPR158 TNK2 GRIA3 GRIN2B	4.29e-05	200	86	5	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	BPTF BRD4 KMT2E ZNF292	1.48e-04	138	86	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	MTHFR ATF7IP ASXL3 SSBP3-AS1	1.99e-04	149	86	4	768877bade04ca0321593b8470b5011ad8270431
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	KMT2C HIVEP2 ATF7IP ANKRD36C	2.37e-04	156	86	4	1545169694f686d28648a68b552c2ae606599d66
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PRUNE2 FOXP4 BMP2K POU2F2	2.43e-04	157	86	4	29622bac6b16bb39cec4319bf4c4f92d33345e8a
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYOT NFATC2 CENPE ASXL3	2.61e-04	160	86	4	8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CELSR3 NFATC2 GRIA3 MYBL1	2.67e-04	161	86	4	d72c572613f8eff3251cb7b1e9dcc76d193b2f21
ToppCell	5'-Adult-LymphNode-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF2 ZNF532 POU2F2 BCL7A	2.67e-04	161	86	4	d8140e7772b4e327dafa3536881a784d3c328d2a
ToppCell	P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KMT2C BAIAP2L1 EVPL RNF139	3.14e-04	168	86	4	8c8dbdbc7053f34e4ca0c5067af502fbea109fc1
ToppCell	3'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF2 TMEM31 BCL7A MYBL1	3.21e-04	169	86	4	203971cceeba150d0e8891c92662545e84c77837
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRUNE2 CENPE CENPI TLN2	3.21e-04	169	86	4	a1efc20e34a81ae32f8d278a5486811ade03ef24
ToppCell	metastatic_Brain-B_lymphocytes-Undetermined\|B_lymphocytes / Location, Cell class and cell subclass	FOXP4 NFATC2 UBAP2L ZNF185	3.36e-04	171	86	4	0d14bc9688c427ba2265984987dc3eea195b19eb
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	PRUNE2 MRTFB CAMK2G APBB2	3.36e-04	171	86	4	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BMP2K POU2F2 YBX3 BCL7A	3.51e-04	173	86	4	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXP4 MTHFR GRIA3 EVPL	3.51e-04	173	86	4	2b448acd5e584f24567204c31b8d74715e92f32a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXP4 MTHFR GRIA3 EVPL	3.51e-04	173	86	4	5086edc29c5a6137ca09877929a1317f9739c801
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAST4 AFF2 GPR158 PDE4DIP	3.58e-04	174	86	4	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NFATC2 CENPE CENPI MYBL1	3.58e-04	174	86	4	7b318796728001c17b4043d2b033330c7be40c78
ToppCell	Severe-B_naive-8\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	APBB2 PLEKHA1 YBX3 BCL7A	3.58e-04	174	86	4	f3f8c924420f46321bd47e2b97f18c7241541599
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TDRD5 INTS12 ZNF185 GRIN2B	3.66e-04	175	86	4	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	LRRC37A LRRC37A3 GRIA3 TLN2	3.66e-04	175	86	4	29fbdfe1d3bfcb063be2bced0128a33176c5b78f
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZEB1 MRTFB APBB2 PLEKHA1	3.82e-04	177	86	4	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAST4 AFF2 GPR158 PDE4DIP	3.91e-04	178	86	4	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	APBB2 PLEKHA1 YBX3 BCL7A	3.91e-04	178	86	4	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APBB2 TLN2 EVPL ATP2B2	3.99e-04	179	86	4	a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC1 GRIA3 ANKRD36C MYBPC1	3.99e-04	179	86	4	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 MRTFB MAST4 APBB2	3.99e-04	179	86	4	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TLK1 ZEB1 MAST4 CENPE	4.07e-04	180	86	4	6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC1 GRIA3 ANKRD36C MYBPC1	4.07e-04	180	86	4	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC1 GRIA3 ANKRD36C MYBPC1	4.07e-04	180	86	4	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	APBB2 POU2F2 YBX3 BCL7A	4.16e-04	181	86	4	ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e
ToppCell	wk_15-18-Epithelial-PNS-SST+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 CELSR3 GRIA3 ATP2B2	4.25e-04	182	86	4	a7e77aaaddabf78c7784f72b3431703fc5ee4a8c
ToppCell	remission-B_naive\|remission / disease stage, cell group and cell class	APBB2 POU2F2 YBX3 BCL7A	4.34e-04	183	86	4	280d55d67f1d44594206da2f3a332c9d799dbdf0
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B-Naive_B_cells\|GI_small-bowel / Manually curated celltypes from each tissue	APBB2 POU2F2 YBX3 BCL7A	4.34e-04	183	86	4	be294d22b91dbcf1e8d22e6a31c39b5caaad4751
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ZEB1 AFF2 GRIN2B PDLIM5	4.34e-04	183	86	4	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	Substantia_nigra-Neuronal\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FOXP4 CELSR3 GPR158 GRIN2B	4.61e-04	186	86	4	3f889083fcffe516388e9b03a5e23af2010ced33
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 MAST4 CAMK2G TLN2	4.61e-04	186	86	4	5784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 GRIA3 POU2F2 GRIN2B	4.61e-04	186	86	4	7278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCell	normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ\|B_lymphocytes / Location, Cell class and cell subclass	MYOT BAIAP2L1 BCL7A MYBL1	4.70e-04	187	86	4	457eb3791a8c5458d81833e0701ac5a9bfdee2bf
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 MAST4 BMP2K PLEKHA1	4.70e-04	187	86	4	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NFATC2 TNRC6C ANKRD36C MYBL1	4.80e-04	188	86	4	f8e6247bedc0ba494c5bb551539cb8ba5a97f557
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	KMT2C BCLAF1 ATF7IP ANKRD36C	4.80e-04	188	86	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	ZEB1 MRTFB MAST4 YBX3	4.80e-04	188	86	4	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZEB1 ATF7IP BCL7A ZNF292	4.80e-04	188	86	4	e239bcdbd210a398a5850cb6fbf171d402f45a4f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NFATC2 TNRC6C ANKRD36C MYBL1	4.80e-04	188	86	4	8155bc5476fc333bedcc78c5ddcc8e4912536caa
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CELSR3 NFATC2 SIGLEC9 POU2F2	4.90e-04	189	86	4	b8cbfc47f3f40b6fccd15899d58c87d07b0001aa
ToppCell	Control-Lymphoid-T_Cytotoxic\|World / Disease state, Lineage and Cell class	ZEB1 NFATC2 ATF7IP MYBL1	4.90e-04	189	86	4	ee4c1d930534788a7759d92dc8ff9c62e6ee2301
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TLK1 ZEB1 ANKRD36C ZNF292	4.99e-04	190	86	4	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CELSR3 GPR158 GRIN2B ATP2B2	4.99e-04	190	86	4	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ATF7IP POU2F2 YBX3 BCL7A	4.99e-04	190	86	4	a7498fe55b7810c482291db782dc5282675d246a
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	APBB2 POU2F2 YBX3 BCL7A	4.99e-04	190	86	4	441770ce7b3c81f36f5b15b8e51794f736462457
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZEB1 MRTFB MAST4 APBB2	5.09e-04	191	86	4	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	APBB2 POU2F2 YBX3 BCL7A	5.09e-04	191	86	4	b374676ac90572d65895052d46469906e2b6fd93
ToppCell	Control-Lymphoid-T_Cytotoxic\|Control / Disease state, Lineage and Cell class	ZEB1 NFATC2 ATF7IP MYBL1	5.09e-04	191	86	4	03b5c5e0941c3402ab3f48cbf3da2a027d110421
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BPTF HELZ KMT2E ZNF292	5.19e-04	192	86	4	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC37A3 PDE4DIP APBB2 TLN2	5.19e-04	192	86	4	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ST6GALNAC1 ZEB1 HIVEP2 TNRC6C	5.19e-04	192	86	4	7ab626a516b07d899175ff12f1c8257688324e4b
Computational	Neighborhood of DLG1	MRTFB CAMK2G ATG2B PLEKHA1 ATP2B2	6.38e-05	79	58	5	GCM_DLG1
Drug	Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A	SECISBP2L SBF1 EP400 CAMK2G PDE4DIP APBB2 TRIOBP TLN2	8.12e-07	197	86	8	4796_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	TLK1 MRTFB HIVEP2 MAST4 CENPE ATF7IP APBB2	4.36e-06	174	86	7	7530_DN
Drug	2,4,4'-trichlorobiphenyl	ILRUN PRUNE2 ZEB1 LRRC37A CELSR3 EP400 CENPE MTHFR DTNB ASXL3 PDE4DIP CENPI TRIOBP PLEKHA1 TLN2 EEF2K GRIN2B ATP2B2	4.40e-06	1411	86	18	ctd:C081766
Drug	2,4,5,2',5'-pentachlorobiphenyl	ILRUN PRUNE2 ZEB1 LRRC37A CELSR3 EP400 CENPE MTHFR DTNB ASXL3 PDE4DIP CENPI TRIOBP PLEKHA1 TLN2 EEF2K GRIN2B ATP2B2	5.89e-06	1441	86	18	ctd:C009828
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	BPTF TLK1 MRTFB CENPE ATF7IP CENPI APBB2	6.08e-06	183	86	7	7498_DN
Drug	PNU-0293363 [326823-19-2]; Down 200; 10uM; PC3; HT_HG-U133A	WDR5B BMP2K CENPE CENPI APBB2 MINDY2 PDLIM5	9.52e-06	196	86	7	6563_DN
Drug	Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; HL60; HT_HG-U133A	TLK1 MTHFR APBB2 GRIA3 ATP2B2 MYBL1 MYBPC1	1.02e-05	198	86	7	3012_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A	HIVEP2 EP400 U2SURP ATG2B TLN2 NUP42 PDLIM5	1.05e-05	199	86	7	7020_DN
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; HL60; HT_HG-U133A	TLK1 MTHFR BRD4 GRIA3 PDLIM5 ZMYM5 MYBL1	1.05e-05	199	86	7	2987_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	BPTF ZEB1 MRTFB HIVEP2 MAST4 ATF7IP	4.70e-05	171	86	6	7535_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	BPTF TLK1 HIVEP2 TRIOBP EVPL BCL7A	5.88e-05	178	86	6	5086_DN
Drug	tributyltin	KDM3A HIVEP2 MAST4 CAMK2G HELZ GRIA3 EEF2K GRIN2B ZNF292	6.54e-05	465	86	9	ctd:C011559
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	HIVEP2 WDR5B TRIOBP BCL7A MINDY2 ZNF292	6.65e-05	182	86	6	1231_DN
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	PDE4DIP CENPI POGZ NUP42 BCL7A MINDY2	8.19e-05	189	86	6	1206_DN
Drug	GW8510; Up 200; 10uM; MCF7; HT_HG-U133A	ILRUN CAMK2G NABP2 TRIOBP TLN2 PDLIM5	8.93e-05	192	86	6	7062_UP
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; HL60; HT_HG-U133A	ZEB1 HIVEP2 NABP2 GRIA3 MINDY2 ATP2B2	9.46e-05	194	86	6	3015_DN
Drug	Azathymine, 6 [932-53-6]; Up 200; 31.4uM; MCF7; HT_HG-U133A	AFF2 MTHFR DTNB BRD4 TNK2 MINDY2	9.46e-05	194	86	6	2827_UP
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	SECISBP2L BPTF HIVEP2 EP400 U2SURP APBB2	9.46e-05	194	86	6	4662_DN
Drug	WY-14643; Up 200; 100uM; MCF7; HG-U133A	CELSR3 SBF1 TNK2 TLN2 EVPL NUP42	9.73e-05	195	86	6	368_UP
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	TLK1 CELSR3 BMP2K APBB2 POGZ MINDY2	9.73e-05	195	86	6	2283_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	AKAP4 MRTFB PDE4DIP APBB2 TNK2 TLN2	9.73e-05	195	86	6	2566_UP
Drug	Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; MCF7; HT_HG-U133A	TLK1 HIVEP2 AFF2 DTNB CAMK2G PDE4DIP	9.73e-05	195	86	6	3212_UP
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; HL60; HT_HG-U133A	ILRUN ZEB1 APBB2 MINDY2 PDLIM5 ZMYM5	9.73e-05	195	86	6	2156_DN
Drug	6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A	MAST4 EP400 TNK2 NUP42 BCL7A PDLIM5	9.73e-05	195	86	6	667_DN
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	MAST4 EP400 CAMK2G TRIOBP EVPL MINDY2	1.00e-04	196	86	6	2056_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A	ZEB1 BMP2K MTHFR APBB2 TNK2 PDLIM5	1.00e-04	196	86	6	1181_UP
Drug	Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	SBF1 MTHFR BRD4 PDE4DIP POU2F2 TLN2	1.00e-04	196	86	6	6229_UP
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	BMP2K PDE4DIP TLN2 EVPL MINDY2 PDLIM5	1.03e-04	197	86	6	7484_UP
Drug	2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A	MRTFB MTHFR APBB2 GRIA3 PDLIM5 MYBL1	1.03e-04	197	86	6	2674_UP
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	BPTF ZEB1 BMP2K BRD4 PDE4DIP TLN2	1.03e-04	197	86	6	2126_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	TLK1 MAST4 SBF1 CAMK2G EVPL BCL7A	1.03e-04	197	86	6	3829_DN
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A	HIVEP2 MAST4 SBF1 CAMK2G TLN2 BCL7A	1.03e-04	197	86	6	1470_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	MRTFB MTHFR PDE4DIP APBB2 MINDY2 ZMYM5	1.06e-04	198	86	6	1178_UP
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SBF1 BMP2K CAMK2G BRD4 APBB2 ZMYM5	1.06e-04	198	86	6	1513_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A	BMP2K BRD4 NABP2 EVPL POGZ ZNF292	1.06e-04	198	86	6	3413_DN
Drug	Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; HL60; HT_HG-U133A	PRUNE2 TLK1 AFF2 MTHFR PDE4DIP APBB2	1.06e-04	198	86	6	2518_UP
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A	HIVEP2 MAST4 SBF1 BMP2K APBB2 PDLIM5	1.06e-04	198	86	6	1534_DN
Drug	Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	SECISBP2L ILRUN HIVEP2 EP400 U2SURP TRIOBP	1.06e-04	198	86	6	6250_DN
Drug	Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; HL60; HT_HG-U133A	AFF2 DTNB APBB2 TNK2 TLN2 PDLIM5	1.06e-04	198	86	6	2917_UP
Drug	Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	UBAP2L BRD4 PDE4DIP POU2F2 PDLIM5 ZMYM5	1.06e-04	198	86	6	7261_UP
Drug	Chenodiol [474-25-9]; Up 200; 10.2uM; HL60; HT_HG-U133A	PRUNE2 MRTFB AFF2 SBF1 MTHFR PDLIM5	1.06e-04	198	86	6	2402_UP
Drug	topiramate; Up 200; 3uM; MCF7; HT_HG-U133A_EA	PRUNE2 MAST4 APBB2 POGZ MINDY2 ZMYM5	1.06e-04	198	86	6	915_UP
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	UBAP2L BRD4 U2SURP TLN2 BCL7A ZMYM5	1.06e-04	198	86	6	3418_DN
Drug	Nabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A	MAST4 AFF2 CELSR3 APBB2 TLN2 MINDY2	1.06e-04	198	86	6	6327_UP
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	SBF1 CAMK2G APBB2 TLN2 EVPL POGZ	1.09e-04	199	86	6	2319_DN
Drug	Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	TLK1 MAST4 EP400 UBAP2L U2SURP BCL7A	1.09e-04	199	86	6	2890_DN
Drug	alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A	DTNB APBB2 GRIA3 POU2F2 ATP2B2 PDLIM5	1.12e-04	200	86	6	3795_UP
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; HL60; HT_HG-U133A	PRUNE2 CELSR3 MTHFR ZNF185 GRIA3 BCL7A	1.12e-04	200	86	6	3081_UP
Drug	Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; MCF7; HT_HG-U133A	CELSR3 SBF1 BMP2K CAMK2G TLN2 ZMYM5	1.12e-04	200	86	6	5516_DN
Drug	testosterone enanthate	PRUNE2 BPTF ZEB1 HIVEP2 BMP2K BCLAF1 PDE4DIP PLEKHA1 ZMYM5	3.21e-04	575	86	9	ctd:C004648
Drug	xenon	AFF2 GRIA3 GRIN2B ATP2B2	3.47e-04	88	86	4	CID000023991
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	KDM3A ZEB1 ATF7IP ZMYM5 ZNF292	3.54e-04	160	86	5	5275_UP
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ZEB1 ATF7IP POU2F2 ZMYM5 ZNF292	3.54e-04	160	86	5	4404_UP
Drug	Parthenolide [20554-84-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	MAST4 CENPI TNK2 TLN2 EVPL	3.86e-04	163	86	5	2885_DN
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	KDM3A ZEB1 ATF7IP ZMYM5 ZNF292	3.97e-04	164	86	5	3963_UP
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A	KDM3A ATF7IP HELZ ZMYM5 ZNF292	4.20e-04	166	86	5	5324_UP
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A	KDM3A ZEB1 ATF7IP ZMYM5 ZNF292	4.80e-04	171	86	5	5026_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA	KDM3A PDE4DIP ATG2B APBB2 MINDY2	5.20e-04	174	86	5	1019_UP
Drug	Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	TLK1 BMP2K PDE4DIP POU2F2 TLN2	6.06e-04	180	86	5	7356_UP
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	TLK1 ZEB1 MRTFB ISG20L2 ZNF292	6.06e-04	180	86	5	4541_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	BPTF MRTFB WDR5B ATF7IP ZNF292	6.70e-04	184	86	5	2321_DN
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	SECISBP2L TLK1 PDE4DIP PDLIM5 MYBL1	6.70e-04	184	86	5	2696_UP
Drug	Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SECISBP2L TLK1 HIVEP2 BMP2K APBB2	6.70e-04	184	86	5	3244_UP
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	BPTF WDR5B APBB2 RNF139 ZNF292	6.86e-04	185	86	5	1114_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	MRTFB PDE4DIP APBB2 TNK2 MYBL1	6.86e-04	185	86	5	2949_UP
Drug	Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; HL60; HG-U133A	SECISBP2L MRTFB BMP2K NABP2 ATG2B	6.86e-04	185	86	5	1567_UP
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	MAST4 BMP2K UBAP2L APBB2 NUP42	6.86e-04	185	86	5	5225_DN
Drug	Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A	BPTF CENPE BRD4 U2SURP CENPI	7.03e-04	186	86	5	5000_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	SECISBP2L KDM3A MAST4 PDE4DIP ZNF292	7.03e-04	186	86	5	6953_UP
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	HIVEP2 BMP2K CENPI POGZ MYBL1	7.20e-04	187	86	5	1656_DN
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	MRTFB WDR5B CENPE ATF7IP POGZ	7.20e-04	187	86	5	7080_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	BPTF BMP2K CENPI HELZ MYBL1	7.20e-04	187	86	5	4989_DN
Drug	trichostatin A; Down 200; 0.1uM; PC3; HG-U133A	TLK1 HIVEP2 UBAP2L POGZ BCL7A	7.20e-04	187	86	5	448_DN
Drug	Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A	U2SURP NABP2 CENPI TRIOBP MINDY2	7.38e-04	188	86	5	2053_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A	SECISBP2L ZEB1 HIVEP2 PDE4DIP APBB2	7.38e-04	188	86	5	1150_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	ZEB1 PDE4DIP APBB2 TLN2 MYBL1	7.38e-04	188	86	5	6143_UP
Drug	ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA	SBF1 EP400 BRD4 BCL7A PDLIM5	7.38e-04	188	86	5	974_UP
Drug	Quercetine dihydrate [6151-25-3]; Up 200; 11.8uM; HL60; HT_HG-U133A	HIVEP2 SIGLEC9 PDE4DIP POU2F2 TLN2	7.56e-04	189	86	5	2499_UP
Drug	0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A	WDR5B U2SURP APBB2 MINDY2 ZNF292	7.56e-04	189	86	5	7392_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	UBAP2L CENPI NUP42 PDLIM5 ZMYM5	7.56e-04	189	86	5	5203_DN
Drug	5-phosphonopentanoic acid	EEF2K GRIN2B	7.59e-04	11	86	2	CID002773807
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	SECISBP2L ZEB1 MRTFB APBB2 PDLIM5	7.74e-04	190	86	5	1971_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	SECISBP2L MRTFB CENPI MINDY2 PDLIM5	7.74e-04	190	86	5	1400_UP
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	SECISBP2L CENPI APBB2 BCL7A MINDY2	7.74e-04	190	86	5	3373_DN
Drug	Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A	AKAP4 AFF2 MTHFR ZNF185 APBB2	7.74e-04	190	86	5	2911_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	SECISBP2L APBB2 PDLIM5 ZMYM5 ZNF292	7.92e-04	191	86	5	4279_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	SBF1 BMP2K CAMK2G PDE4DIP MINDY2	7.92e-04	191	86	5	2937_DN
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A	BMP2K CAMK2G U2SURP APBB2 ZNF292	8.11e-04	192	86	5	7155_DN
Drug	troglitazone; Down 200; 10uM; HL60; HT_HG-U133A	EP400 CAMK2G BCL7A PDLIM5 ZMYM5	8.11e-04	192	86	5	1173_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A	HIVEP2 MAST4 MTHFR APBB2 POU2F2	8.30e-04	193	86	5	2829_UP
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	TLK1 HIVEP2 MAST4 CELSR3 CAMK2G	8.30e-04	193	86	5	3197_DN
Drug	Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; MCF7; HT_HG-U133A	UBAP2L U2SURP TRIOBP EVPL MYBL1	8.30e-04	193	86	5	6235_DN
Drug	Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A	BPTF HIVEP2 BMP2K UBAP2L APBB2	8.30e-04	193	86	5	2098_DN
Drug	PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A	BMP2K CENPE BRD4 PDE4DIP EVPL	8.30e-04	193	86	5	7388_DN
Drug	5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA	SBF1 BMP2K PDE4DIP BCL7A PDLIM5	8.30e-04	193	86	5	950_UP
Drug	Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A	TLK1 PLEKHA1 EVPL MINDY2 PDLIM5	8.50e-04	194	86	5	3481_UP
Drug	Ethamivan [304-84-7]; Down 200; 18uM; PC3; HT_HG-U133A	MAST4 TNK2 EVPL MINDY2 PDLIM5	8.50e-04	194	86	5	7260_DN
Drug	Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; MCF7; HT_HG-U133A	PRUNE2 ZEB1 BMP2K TRIOBP GRIA3	8.50e-04	194	86	5	5609_UP
Drug	17-AAG; Up 200; 1uM; SKMEL5; HG-U133A	MAST4 PDE4DIP ZNF185 APBB2 TLN2	8.50e-04	194	86	5	505_UP
Drug	Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A	SECISBP2L AFF2 APBB2 TNK2 EVPL	8.50e-04	194	86	5	2825_UP
Disease	Neurodevelopmental Disorders	KMT2C ASXL3 POGZ GRIN2B KMT2E ZNF292	1.78e-07	93	78	6	C1535926
Disease	Intellectual Disability	BPTF KMT2C HIVEP2 BRD4 POGZ GRIN2B SUZ12 KMT2E ZNF292	2.81e-06	447	78	9	C3714756
Disease	cervical cancer (is_implicated_in)	KDM3A MTHFR KMT2E	6.85e-05	30	78	3	DOID:4362 (is_implicated_in)
Disease	body weight	SECISBP2L ILRUN BPTF HIVEP2 MAST4 INTS12 NFATC2 ASXL3 PLEKHA1 TLN2 BCL7A ABHD17C	1.13e-04	1261	78	12	EFO_0004338
Disease	Abnormality of the skeletal system	SUZ12 ZNF292	1.91e-04	8	78	2	C4021790
Disease	Abnormality of the face	BRD4 ZNF292	2.45e-04	9	78	2	C4025871
Disease	Endometrial Neoplasms	ZEB1 MTHFR SUZ12	4.94e-04	58	78	3	C0014170
Disease	Antihypertensive use measurement	HIVEP2 NFATC2 PLEKHA1 ATP2B2 ABHD17C	6.96e-04	265	78	5	EFO_0009927
Disease	Alopecia, Male Pattern	MTHFR BRD4	7.08e-04	15	78	2	C4083212
Disease	Androgenetic Alopecia	MTHFR BRD4	7.08e-04	15	78	2	C0162311
Disease	Female pattern alopecia (disorder)	MTHFR BRD4	7.08e-04	15	78	2	C0263477
Disease	congenital heart disease (implicated_via_orthology)	KMT2C WDR5B MYBPC1	8.21e-04	69	78	3	DOID:1682 (implicated_via_orthology)
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	CAMK2G ZNF292	9.14e-04	17	78	2	DOID:0060307 (is_implicated_in)
Disease	Endometrial Carcinoma	ZEB1 MTHFR SUZ12	9.29e-04	72	78	3	C0476089
Disease	squamous cell carcinoma (is_implicated_in)	KMT2C MTHFR	1.03e-03	18	78	2	DOID:1749 (is_implicated_in)
Disease	Myeloid Leukemia	ATG2B KMT2E	1.03e-03	18	78	2	C0023470
Disease	Leukemia, Monocytic, Chronic	ATG2B KMT2E	1.03e-03	18	78	2	C0023466
Disease	intellectual disability (implicated_via_orthology)	HIVEP2 ATF7IP POGZ	1.05e-03	75	78	3	DOID:1059 (implicated_via_orthology)
Disease	Pseudopelade	MTHFR BRD4	1.15e-03	19	78	2	C0086873
Disease	Alopecia	MTHFR BRD4	1.15e-03	19	78	2	C0002170
Disease	Nystagmus	MAST4 AFF2	1.40e-03	21	78	2	HP_0000639
Disease	visceral adipose tissue measurement	BPTF HIVEP2 GPR158 HELZ PDLIM5 ABHD17C	1.74e-03	481	78	6	EFO_0004765
Disease	cerebellum cortex volume change measurement, age at assessment	HIVEP2 ABHD17C	2.15e-03	26	78	2	EFO_0008007, EFO_0021497
Disease	Sezary Syndrome	KMT2C ZEB1	2.32e-03	27	78	2	C0036920
Disease	Adenoid Cystic Carcinoma	KMT2C TLK1 MYBL1	2.39e-03	100	78	3	C0010606

Protein segments in the cluster

Peptide	Gene	Start	Entry
GSQSEPNNSQTQPKQ	TDRD5	861	Q8NAT2
TKPQSPAQNATSSQD	EP400	751	Q96L91
AEQGQQDPNKNLSPT	APBB2	111	Q92870
NNSSNSNVSKKEPAP	BRD4	576	O60885
AAKNTNNNQSPSAPP	AKAP4	181	Q5JQC9
NGKNTPSPVSLNNVS	AFF2	1206	P51816
SQPQKVGQDAANSSN	C17orf78	246	Q8N4C9
NPQNSNPEGTSNKMA	ANKRD26P1	231	Q6NSI1
IANFTNQKNISNPPD	BMP2K	606	Q9NSY1
SSKPQVAAQSQPQSN	BPTF	2446	Q12830
LKQNSSPPSSLNKNN	ATP2B2	1196	Q01814
PKQPSQNDSANSVEV	ATG2B	1771	Q96BY7
NLTSQQKNLSNTPEP	ASXL3	796	Q9C0F0
ALDPKANFSTNNSNP	TNK2	916	Q07912
NNTGKPATSSANQKP	INTS12	316	Q96CB8
SINSNPVSSQKQPAL	ANKRD36C	261	Q5JPF3
QQNATSQRAAKNGPP	NFATC2	866	Q13469
TINSQPNINGKPSSD	MTHFR	481	P42898
INNENPSPTQQEAAA	LRRC37A3	486	O60309
ENKLPNSDFSQATPN	KMT2C	3681	Q8NEZ4
INNENPSPTQQEAAA	LRRC37A2	486	A6NM11
INNENPSPTQQEAAA	LRRC37A	486	A6NMS7
SNSDNTETKDPAPQN	GPR158	946	Q5T848
NSPVSPNTQDKSVGQ	KIAA1109	1286	Q2LD37
KNTQNFKPAPATNTQ	GRIA3	861	P42263
PGNDQPVSFNLNNTS	FAM205BP	61	Q63HN1
QQAPSGSDLANPQAQ	EVPL	511	Q92817
SALNNATPNTPRQNT	MRTFB	361	Q9ULH7
PQKNAPQNSTQAHSE	ISG20L2	151	Q9H9L3
NGPDTNHQNPQNKTS	POU2F2	36	P09086
PAAQNLPANTQQATS	KMT2E	1501	Q8IZD2
SPGNNDSKQSASAVQ	FOXP4	86	Q8IVH2
DNTKKANNSQEPSPQ	PDLIM5	301	Q96HC4
PNKQIAESANSSSPQ	HELZ	1871	P42694
LFKAQNAPSPGQSQA	SBF1	1221	O95248
PGFPVNNSSSDNAQN	NUP42	231	O15504
TQRQAGSDPNPNKEN	FRG2C	56	A6NGY1
NPFASPQKNRQSDEN	ILRUN	211	Q9H6K1
SKDPRQQSTPQAANS	KDM3A	311	Q9Y4C1
FNNPATAAPNSQRVN	BAIAP2L1	301	Q9UHR4
NTGPNNSNTTFQKRP	BCLAF1	816	Q9NYF8
QISPSNSSLKNPQAG	BCL9L	86	Q86UU0
HEQASQPTPEKAQQN	DTNB	461	O60941
QATAAAAAAQPAPQQ	ABHD17C	61	Q6PCB6
PVSPGKTVNDVNSNN	ATF7IP	671	Q6VMQ6
NRQTDKSPSQPAANT	MAST4	2351	O15021
SSDEQKQQPPNSFSQ	COQ9	46	O75208
PITDDPSSNQNVNSK	EEF2K	41	O00418
PSNSKNISKHGQNNP	CENPI	36	Q92674
LDTSKDAANNNQPDP	CELSR3	2976	Q9NYQ7
KQENSSNSSPAPEPN	BCL7A	106	Q4VC05
GAQVNPTTQDNKNPH	CENPE	2356	Q02224
MPQSNNKNSLVSPAQ	CAMK2G	341	Q13555
ENQPVSAQQNSPTKF	MYBL1	326	P10243
KDNSNVSNNNGFIPP	RNF139	596	Q8WU17
TQAQQGQPAQASPSS	MINDY2	576	Q8NBR6
SFSAQPQNLNTDGPN	TNRC6C	171	Q9HCJ0
PPDLNDSNQAQVDAN	PRUNE2	406	Q8WUY3
NKSNPFCDNQQSSPD	PRUNE2	1751	Q8WUY3
AVQSPGQSNQTTNPK	POGZ	271	Q7Z3K3
ANTDQDAPVATNNPA	SIGLEC9	66	Q9Y336
PENNALNTQTQPKAH	ST6GALNAC1	81	Q9NSC7
DQQASPGQQKSSNCS	SECISBP2L	1071	Q93073
SPQERSQQNQSAPKG	SSBP3-AS1	56	Q7Z2R9
QNIPRSSSTQQDNPK	TRIOBP	821	Q9H2D6
SSRFADQKNPPNQSS	U2SURP	161	O15042
VNPGNTNSSPKHNNT	ANKHD1	1896	Q8IWZ3
QQLKPNNSNAPNEDQ	TMEM31	11	Q5JXX7
NSQAPSTNSEPKQRK	TLK1	356	Q9UKI8
PLSIKPATQNSANQN	ZNF532	976	Q9HCE3
SSSANQSKEVPENPN	WDR5B	16	Q86VZ2
KENQQATSGPNQPSV	YBX3	311	P16989
SDNQSSSPQPAQQKL	UBAP2L	471	Q14157
SLPAQGQAQNSAQSP	SEC16A	1086	O15027
HKNDKPSPNSENEQN	SUZ12	166	Q15022
PNKAVQNDSNPSASQ	NABP2	121	Q9BQ15
PSVNTVQNNKLPDSS	ZNF292	1796	O60281
AKNNDQPQSANANEP	ZEB1	656	P37275
EKSFNNNSSVSPPQQ	ZNF347	211	Q96SE7
QSASFPSNQKQPGVD	ZMYM5	201	Q9UJ78
ANNNNSVGQAVDPPS	ZXDA	646	P98168
AASQNAAVSNKNPAA	TLN2	936	Q9Y4G6
PKQSDSQPNSDNLSR	PLEKHA1	116	Q9HB21
SAEQQISPPNTNAKS	HIVEP2	406	P31629
DSSSQPQQQFPKANG	ZNF185	96	O15231
NQNFPASTDPGNKQL	PDE4DIP	2091	Q5VU43
QQSSAGQPINAKPSQ	MYOT	121	Q9UBF9
TPPGEEQAKQNANSQ	MYBPC1	41	Q00872
VPNNKNPRAFNGSSN	GRIN2B	1456	Q13224